Home / Indometacin / Canada
CA ATC M01AB01 · updated 2 Nov 2026
Indometacin shortage in Canada
Is there an Indometacin shortage in Canada?
Yes. As of 2 Nov 2026, 4 Indometacin products are reported short in Canada, the first since 10 Mar 2017. The company estimate for the return is 30 Dec 2026 (latest 10 Jul 2027). Main reason: manufacturing problem.
Also short in Spain, Austria, Czechia. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO INDOMETHACIN CAP 25MG (100 BTL & 1000 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO INDOMETHACIN CAP 50MG (100 BTL & 500 BTL) | APOTEX INC | 10 Mar 2017 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-INDOMETHACIN (100 & 500) | TEVA CANADA LIMITED | 18 Feb 2026 | 10 Jul 2027 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | TEVA-INDOMETHACIN (100,1000) | TEVA CANADA LIMITED | 29 Oct 2026 | 30 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.